- Previous Close
1,181.18 - Open
1,162.88 - Bid --
- Ask --
- Day's Range
1,162.88 - 1,162.88 - 52 Week Range
1,139.30 - 1,162.88 - Volume
1,100 - Avg. Volume
131 - Market Cap (intraday)
63.748B - Beta (5Y Monthly) 1.09
- PE Ratio (TTM)
-- - EPS (TTM)
-34.89 - Earnings Date Feb 25, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
www.procept-biorobotics.comRecent News: PRCT.MX
View MorePerformance Overview: PRCT.MX
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PRCT.MX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PRCT.MX
View MoreValuation Measures
Market Cap
56.01B
Enterprise Value
50.95B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
13.54
Price/Book (mrq)
7.95
Enterprise Value/Revenue
11.38
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-40.72%
Return on Assets (ttm)
-12.86%
Return on Equity (ttm)
-26.77%
Revenue (ttm)
224.5M
Net Income Avi to Common (ttm)
-91.41M
Diluted EPS (ttm)
-34.89
Balance Sheet and Cash Flow
Total Cash (mrq)
333.72M
Total Debt/Equity (mrq)
20.45%
Levered Free Cash Flow (ttm)
-78.24M